Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-25-028232

Options or other derivatives

  • Director returned 184,984 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Steinhart Richard I Director 2025-03-31 Returned to the company · Stock Option (Right to Buy) −2,500 0 D: show line 1 in the form
Steinhart Richard I Director 2025-03-31 Returned to the company · Stock Option (Right to Buy) −2,500 0 D: show line 2 in the form
Steinhart Richard I Director 2025-03-31 Returned to the company · Stock Option (Right to Buy) −2,500 0 D: show line 3 in the form
Steinhart Richard I Director 2025-03-31 Returned to the company · Stock Option (Right to Buy) −8,333 0 D: show line 4 in the form
Steinhart Richard I Director 2025-03-31 Returned to the company · Stock Option (Right to Buy) −8,333 0 D: show line 5 in the form
Steinhart Richard I Director 2025-03-31 Returned to the company · Stock Option (Right to Buy) −18,351 0 D: show line 6 in the form
Steinhart Richard I Director 2025-03-31 Returned to the company · Stock Option (Right to Buy) −72,156 0 D: show line 7 in the form
Steinhart Richard I Director 2025-03-31 Returned to the company · Stock Option (Right to Buy) −70,311 0 D: show line 8 in the form
Loading xslF345X05/ownership.xml…